This ad will auto close in 10 seconds
USFDA actions hurting exports, need govt intervention: Dr Reddy's

USFDA actions hurting exports, need govt intervention: Dr Reddy's

Asserting that regulatory action by the US Food and Drug Administration (USFDA) on leading Indian firms has impacted exports from the country, Dr Reddy's Laboratories Chairman Satish Reddy Wednesday asked for a dialogue between government and US health regulator.

Give exemption from drug price control for 5 years: Mazumdar-Shaw

Give exemption from drug price control for 5 years: Mazumdar-Shaw

Seeking a five-year exemption from drug price control, Biocon CMD Kiran Mazumdar-Shaw Wednesday asked the government to refrain from 'ad hoc' measures so as to enable the pharma sector to build scale to be globally competitive.

Expert Analysis on Pharma Sector

Share Bazar, Mandi Live, Aap Ka Bazar, First Trade, Big Debate etc.

Expert on India's pharma sector

Expert on India's pharma sector

Expert on India's pharma sector

See the opportunities in pharma sector

See the opportunities in pharma sector

The stocks in the Pharma sector performed on a higher note yesterday. Listen to our experts share opportunities and projections in the sector.

Share Bazaar Live: Expert on Pharma Sector

Check out our expert's advice on the beaten down sector, the pharma sector.

Now, FSSAI in soup as 11 food, pharma organisations seek CBI inquiry against the regulator

As many as 11 industry bodies related to food and pharma sectors Thursday alleged that the food regulator FSSAI has become "den of corruption" and demanded a CBI inquiry into the functioning of the authority, which shot to limelight over the Maggi issue.

Govt assures all help to boost pharma exports

Government Tuesday assured the pharma industry of "every possible help" in resolving its issues related to exports and said efforts would be made to expedite work on different proposals to realise the full potential of the sector.

PSUs in pharma sector will not be sold: Ananth Kumar

Public sector undertakings in pharmaceuticals sector will not be sold but their assets will be leveraged to make them financially viable, the government said today.

Cipla elevates Samina Vaziralli to its board

Drug major Cipla Thursday announced the appointment of Samina Vaziralli as executive director on its board, paving way for a bigger role for her, nearly two weeks after another heir apparent Kamil Hamied quiting the pharma company.

Govt approves FDI worth Rs 4,000 cr in pharma sector

Govt approves FDI worth Rs 4,000 cr in pharma sector

Proposals for foreign direct investment amounting to around Rs 4,000 crore by four pharma and medical devices firms, including Torrent Pharmaceuticals and Biocon's research services arm Syngene, were on Wednesday approved by the government.

NPPA gives deadline to drug cos for online data registration

Drug price regulator NPPA has given pharma firms time till Friday to register for online database with 19 out of top 100 drug makers yet to respond after repeated reminders.

'Pharma industry grappling with pricing, regulatory issues'

The buoyant pharmaceutical industry is still struggling to deal with the challenges around pricing in the domestic market, increased regulations as well as data integrity, says an EY survey.

Glenmark issues over 1 cr shares to Aranda, raises Rs 945 cr

Glenmark Pharmaceuticals has raised Rs 945 crore by issuing over 1 crore shares to Aranda Investments, an indirect subsidiary of Temasek Holdings.

Dr Reddy's Lab to enter Japanese market through a partner

Pharmaceutical major Dr Reddy's Laboratories Tuesday said it has plans to enter Japanese market through partnerships for specific products.

'Pharma exports may have grown 2.2% to $15.2 bn in FY15'

Indian pharma exports are estimated to have grown, but at a slower pace of 2.2 percent to about USD 15.2 billion during the financial year ended March 2015 against USD 14.9 billion in the previous fiscal, said a top official of Pharmexcil, an export promotion body, Monday.

Shanghvi did not buy Daiichi Sankyo's shares: Sun Pharma

The company was clarifying on speculations that Sanghvi, who holds 9.61 percent stake in Sun Pharma, had bought shares when Daiichi Sankyo exited from the Indian firm.

Daiichi Sankyo to offload stake in Sun Pharma worth Rs 22,000 cr

Japanese drug maker Daiichi Sankyo Monday said it board has approved selling a part or entire 9 percent holding worth over Rs 22,000 crore in Indian drug major Sun Pharmaceutical.

Pharma shares fall; Sun Pharma top loser on Sensex

Pharma shares fell by up to 3.6 percent Thursday amid reports that global brokerage firm Bank of America Merrill Lynch has downgraded some of the drug firms.

Govt allows pharma companies to hike prices of 509 essential drugs

The government has allowed pharmaceutical companies to hike rates of 509 essential medicines used for treating various ailments like diabetes, hepatitis and cancer by 3.84 percent with effect from April 1.